Evolus Announces Publication of Safety and Duration Data from Phase 2 Study for "Extra-Strength" 40U Formulation of Jeuveau®

2d ago, source:

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, ...

Evolus, Inc. (NASDAQ:EOLS) is favoured by institutional owners who hold 57% of the company

13d ago, source:

Every investor in Evolus, Inc. ( NASDAQ:EOLS) should be aware of the most powerful shareholder groups. The group holding the ...

Does Evolus, Inc. (EOLS) Have the Potential to Rally 63.24% as Wall Street Analysts Expect?

1mon ago, source: Hosted on MSN

S hares of Evolus, Inc. (EOLS) have gained 5% over the past four weeks to close the last trading session at $14.09, but there could still be a solid upside left in the stock if short-term price ...

Evolus Announces Pricing of $50.0 Million Underwritten Offering of Common Stock

1mon ago, source: Stockhouse

Evolus, Inc. (Nasdaq: EOLS) announced today the pricing of its underwritten offering of 3,554,000 shares of its common stock at a underwritten offering price of $14.07 per share, which is equal to the ...

Evolus Poised for Growth: Surpassing Q4 Expectations and Accelerating Profitability

1mon ago, source: Business Insider

Begin your TipRanks Premium journey today. Evolus (EOLS) Company Description: Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and ...

Evolus reports 6-month efficacy of Jeuveau in glabellar lines study

2d ago, source: Investing

NEWPORT BEACH, Calif. - Evolus, Inc. (NASDAQ: NASDAQ:EOLS), a performance beauty company, has announced the publication of a study in the Aesthetic Surgery Journal that supports the safety and ...

Evolus Reports Pricing Of $50 Mln Underwritten Offering Of Common Stock

1mon ago, source: Nasdaq

(RTTNews) - Monday, Evolus, Inc. (EOLS) announced the pricing of the underwritten offering of 3,554,000 shares of its common stock at $14.07 per share, matching the closing price on Friday ...

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

1mon ago, source: Nasdaq

NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of ...

Evolus Stock (NASDAQ:EOLS), Quotes and News Summary

1mon ago, source: Benzinga.com

Shares of SoFi Technologies, Inc. (NASDAQ: SOFI) rose sharply during Monday’s session after the company reported better-than-expected fourth-quarter revenue. Avi Kapoor Evolus Set For Promising ...

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

7d ago, source: Yahoo Finance

NEWPORT BEACH, Calif., April 12, 2024--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a ...